Research ArticleRESEARCH ARTICLE

Identification and Characterization of the Sulfate Precipitate in GI147211C IV Formulation

Wei-Qin Tong, Jerry Clark, Michael L. Franklin, Jill P. Jozwiakowski, Joanne B. Lemmo, Jay M. Sisco and Sheila R. Whight
PDA Journal of Pharmaceutical Science and Technology September 1996, 50 (5) 326-329;

Article Information

vol. 50 no. 5 326-329
PubMed 
8973120
Published By 
Parenteral Drug Association (PDA)
Print ISSN 
1079-7440
Online ISSN 
1948-2124
History 
  • Received August 21, 1995
  • Accepted February 22, 1996
  • Published online September 1, 1996.
Copyright & Usage 
Copyright © Parenteral Drug Association. All rights reserved.

Author Information

  1. Wei-Qin Tong*Δ,
  2. Jerry Clark‡,
  3. Michael L. Franklin‡,
  4. Jill P. Jozwiakowski*§,
  5. Joanne B. Lemmo‡,
  6. Jay M. Sisco* and
  7. Sheila R. Whight‡
    1. Δ Author to whom correspondence should be addressed: Department of Pharmaceutics, Glaxo Wellcome Inc., Five Moore Drive, Research Triangle Park, North Carolina, 27709.
    2. § Current address: 3M Pharmaceuticals. St. Paul, MN.
    3. Current address: CytRx Corporation, Atlanta, GA.

    Cited By...

    Back to top

    In This Issue

    Download PDF
    Article Alerts
    Email Article
    Citation Tools
    Identification and Characterization of the Sulfate Precipitate in GI147211C IV Formulation
    Wei-Qin Tong, Jerry Clark, Michael L. Franklin, Jill P. Jozwiakowski, Joanne B. Lemmo, Jay M. Sisco, Sheila R. Whight
    PDA Journal of Pharmaceutical Science and Technology Sep 1996, 50 (5) 326-329;
    Twitter logo Facebook logo Mendeley logo

    Jump to section